Biomerica, Inc. - BMRA

SEC FilingsOur BMRA Tweets

About Gravity Analytica

Recent News

  • 09.09.2025 - Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
  • 09.03.2025 - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
  • 08.29.2025 - Biomerica Reports Fiscal 2025 Year End Results
  • 08.14.2025 - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
  • 07.02.2025 - InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
  • 06.26.2025 - Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
  • 06.06.2025 - Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
  • 06.05.2025 - Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
  • 05.22.2025 - Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
  • 05.07.2025 - PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

Recent Filings

  • 08.29.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 06.06.2025 - 3 Initial statement of beneficial ownership of securities
  • 06.06.2025 - EX-99.1 EX-99.1
  • 06.06.2025 - 8-K Current report
  • 04.16.2025 - EX-99.1 EX-99.1
  • 04.16.2025 - 8-K Current report